nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Ticagrelor—coronary artery disease	0.0753	0.146	CbGbCtD
Tiagabine—CYP3A4—Fenofibrate—coronary artery disease	0.0671	0.13	CbGbCtD
Tiagabine—CYP3A4—Gemfibrozil—coronary artery disease	0.0536	0.104	CbGbCtD
Tiagabine—CYP3A4—Clopidogrel—coronary artery disease	0.0465	0.0904	CbGbCtD
Tiagabine—CYP3A4—Eplerenone—coronary artery disease	0.0432	0.0841	CbGbCtD
Tiagabine—CYP3A4—Enalapril—coronary artery disease	0.0385	0.0749	CbGbCtD
Tiagabine—CYP3A4—Rosuvastatin—coronary artery disease	0.03	0.0583	CbGbCtD
Tiagabine—CYP3A4—Ezetimibe—coronary artery disease	0.03	0.0583	CbGbCtD
Tiagabine—CYP3A4—Simvastatin—coronary artery disease	0.0279	0.0542	CbGbCtD
Tiagabine—CYP3A4—Lovastatin—coronary artery disease	0.0273	0.053	CbGbCtD
Tiagabine—CYP3A4—Pravastatin—coronary artery disease	0.0273	0.053	CbGbCtD
Tiagabine—CYP3A4—Atorvastatin—coronary artery disease	0.0248	0.0483	CbGbCtD
Tiagabine—CYP3A4—Losartan—coronary artery disease	0.0227	0.0442	CbGbCtD
Tiagabine—SLC6A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A6—coronary artery disease	0.0106	0.112	CbGpPWpGaD
Tiagabine—SLC6A1—Amine compound SLC transporters—SLC6A6—coronary artery disease	0.00733	0.0777	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—PRDX6—coronary artery disease	0.00321	0.034	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—CES3—coronary artery disease	0.00321	0.034	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A6—coronary artery disease	0.00287	0.0304	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC6A6—coronary artery disease	0.00207	0.0219	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—ITGB3—coronary artery disease	0.00187	0.0198	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—coronary artery disease	0.00185	0.0196	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTM2—coronary artery disease	0.00173	0.0184	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—AGT—coronary artery disease	0.00166	0.0176	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—MAPK14—coronary artery disease	0.00158	0.0168	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SOD3—coronary artery disease	0.0014	0.0148	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GCLM—coronary artery disease	0.0014	0.0148	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TXNRD1—coronary artery disease	0.00135	0.0143	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	0.0013	0.0138	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GPX2—coronary artery disease	0.00125	0.0132	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTA1—coronary artery disease	0.0012	0.0127	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNJ8—coronary artery disease	0.00118	0.0125	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.00117	0.0124	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—coronary artery disease	0.00104	0.011	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GPX3—coronary artery disease	0.00101	0.0107	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—HK2—coronary artery disease	0.000988	0.0105	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	0.000947	0.01	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GCLC—coronary artery disease	0.00091	0.00964	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNJ2—coronary artery disease	0.000895	0.00948	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000894	0.00947	CbGpPWpGaD
Tiagabine—CYP3A4—Liver X Receptor Pathway—ABCG5—coronary artery disease	0.000878	0.0093	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB2—coronary artery disease	0.000863	0.00914	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	0.00084	0.00889	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000779	0.00825	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000775	0.00821	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000775	0.00821	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HSPA1A—coronary artery disease	0.00076	0.00805	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000753	0.00797	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—coronary artery disease	0.000752	0.00796	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—SULT1E1—coronary artery disease	0.000733	0.00776	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GGT1—coronary artery disease	0.000711	0.00753	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000694	0.00735	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000694	0.00735	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000689	0.00729	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PLCB3—coronary artery disease	0.000685	0.00726	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000662	0.00701	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—SULT1E1—coronary artery disease	0.000648	0.00686	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFBR2—coronary artery disease	0.000638	0.00676	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTP1—coronary artery disease	0.000638	0.00676	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HMOX1—coronary artery disease	0.00063	0.00667	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000589	0.00623	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTM1—coronary artery disease	0.000587	0.00621	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HGF—coronary artery disease	0.000587	0.00621	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.00058	0.00615	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ALDH2—coronary artery disease	0.000577	0.00611	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—AGER—coronary artery disease	0.000566	0.00599	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—coronary artery disease	0.000557	0.0059	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000555	0.00588	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000555	0.00588	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—SULT1A1—coronary artery disease	0.000549	0.00581	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PLN—coronary artery disease	0.00054	0.00572	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTA1—coronary artery disease	0.000536	0.00568	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CAMK2D—coronary artery disease	0.000528	0.00559	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000502	0.00531	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—SULT1A1—coronary artery disease	0.000485	0.00514	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000481	0.0051	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000481	0.0051	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—coronary artery disease	0.000475	0.00503	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PLCB1—coronary artery disease	0.000451	0.00477	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000427	0.00452	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000427	0.00452	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.000394	0.00417	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HK1—coronary artery disease	0.000394	0.00417	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.000394	0.00417	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP2C19—coronary artery disease	0.000387	0.0041	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP2C19—coronary artery disease	0.000372	0.00394	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—coronary artery disease	0.000346	0.00367	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—coronary artery disease	0.00033	0.00349	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000322	0.00341	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin activation and detoxification—GGT1—coronary artery disease	0.000304	0.00322	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.000302	0.0032	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.000295	0.00312	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000292	0.00309	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—HADH—coronary artery disease	0.000277	0.00293	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000276	0.00293	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—coronary artery disease	0.00027	0.00286	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—coronary artery disease	0.000266	0.00281	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTM1—coronary artery disease	0.000262	0.00277	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000257	0.00272	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CREB1—coronary artery disease	0.000247	0.00262	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB1—coronary artery disease	0.000239	0.00253	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—coronary artery disease	0.000238	0.00252	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—coronary artery disease	0.00023	0.00244	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—coronary artery disease	0.000227	0.00241	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000218	0.00231	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—ALDH2—coronary artery disease	0.000204	0.00216	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000202	0.00213	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	0.000197	0.00208	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000193	0.00205	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	0.000187	0.00198	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—MAPK1—coronary artery disease	0.000182	0.00193	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—SULT4A1—coronary artery disease	0.000178	0.00189	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—coronary artery disease	0.000178	0.00189	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—SULT4A1—coronary artery disease	0.000176	0.00186	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	0.000161	0.0017	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	0.000159	0.00168	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.000153	0.00162	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—MAPK1—coronary artery disease	0.00014	0.00148	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	0.000134	0.00142	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CAT—coronary artery disease	0.000131	0.00139	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	0.00013	0.00138	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTM2—coronary artery disease	0.000127	0.00135	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTM2—coronary artery disease	0.000125	0.00133	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—coronary artery disease	0.000121	0.00128	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	0.000121	0.00128	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	0.000119	0.00126	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	0.000113	0.0012	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	0.000113	0.00119	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GCLM—coronary artery disease	0.000102	0.00108	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	9.92e-05	0.00105	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	9.79e-05	0.00104	CbGpPWpGaD
Tiagabine—Pruritus—Olmesartan—coronary artery disease	9.54e-05	0.000244	CcSEcCtD
Tiagabine—Decreased appetite—Losartan—coronary artery disease	9.53e-05	0.000243	CcSEcCtD
Tiagabine—Abdominal pain—Captopril—coronary artery disease	9.52e-05	0.000243	CcSEcCtD
Tiagabine—Body temperature increased—Captopril—coronary artery disease	9.52e-05	0.000243	CcSEcCtD
Tiagabine—Dizziness—Simvastatin—coronary artery disease	9.49e-05	0.000242	CcSEcCtD
Tiagabine—Rash—Ezetimibe—coronary artery disease	9.49e-05	0.000242	CcSEcCtD
Tiagabine—Dermatitis—Ezetimibe—coronary artery disease	9.48e-05	0.000242	CcSEcCtD
Tiagabine—Confusional state—Ramipril—coronary artery disease	9.48e-05	0.000242	CcSEcCtD
Tiagabine—Discomfort—Timolol—coronary artery disease	9.47e-05	0.000242	CcSEcCtD
Tiagabine—Asthenia—Niacin—coronary artery disease	9.46e-05	0.000242	CcSEcCtD
Tiagabine—Fatigue—Losartan—coronary artery disease	9.45e-05	0.000241	CcSEcCtD
Tiagabine—Headache—Ezetimibe—coronary artery disease	9.43e-05	0.000241	CcSEcCtD
Tiagabine—Malaise—Lisinopril—coronary artery disease	9.42e-05	0.000241	CcSEcCtD
Tiagabine—Oedema—Ramipril—coronary artery disease	9.4e-05	0.00024	CcSEcCtD
Tiagabine—Vertigo—Lisinopril—coronary artery disease	9.38e-05	0.00024	CcSEcCtD
Tiagabine—Dry mouth—Timolol—coronary artery disease	9.37e-05	0.000239	CcSEcCtD
Tiagabine—Pain—Losartan—coronary artery disease	9.37e-05	0.000239	CcSEcCtD
Tiagabine—Constipation—Losartan—coronary artery disease	9.37e-05	0.000239	CcSEcCtD
Tiagabine—Syncope—Lisinopril—coronary artery disease	9.37e-05	0.000239	CcSEcCtD
Tiagabine—Vomiting—Eplerenone—coronary artery disease	9.37e-05	0.000239	CcSEcCtD
Tiagabine—Feeling abnormal—Furosemide—coronary artery disease	9.36e-05	0.000239	CcSEcCtD
Tiagabine—Leukopenia—Lisinopril—coronary artery disease	9.35e-05	0.000239	CcSEcCtD
Tiagabine—Nausea—Fenofibrate—coronary artery disease	9.33e-05	0.000238	CcSEcCtD
Tiagabine—Pruritus—Niacin—coronary artery disease	9.32e-05	0.000238	CcSEcCtD
Tiagabine—Asthenia—Pravastatin—coronary artery disease	9.31e-05	0.000238	CcSEcCtD
Tiagabine—Gastrointestinal pain—Furosemide—coronary artery disease	9.29e-05	0.000237	CcSEcCtD
Tiagabine—Rash—Eplerenone—coronary artery disease	9.29e-05	0.000237	CcSEcCtD
Tiagabine—Urticaria—Perindopril—coronary artery disease	9.28e-05	0.000237	CcSEcCtD
Tiagabine—Hypersensitivity—Trandolapril—coronary artery disease	9.28e-05	0.000237	CcSEcCtD
Tiagabine—Dermatitis—Eplerenone—coronary artery disease	9.28e-05	0.000237	CcSEcCtD
Tiagabine—Diarrhoea—Valsartan—coronary artery disease	9.27e-05	0.000237	CcSEcCtD
Tiagabine—Confusional state—Timolol—coronary artery disease	9.27e-05	0.000237	CcSEcCtD
Tiagabine—Shock—Ramipril—coronary artery disease	9.25e-05	0.000236	CcSEcCtD
Tiagabine—Hypersensitivity—Enalapril—coronary artery disease	9.25e-05	0.000236	CcSEcCtD
Tiagabine—Body temperature increased—Perindopril—coronary artery disease	9.24e-05	0.000236	CcSEcCtD
Tiagabine—Abdominal pain—Perindopril—coronary artery disease	9.24e-05	0.000236	CcSEcCtD
Tiagabine—Palpitations—Lisinopril—coronary artery disease	9.23e-05	0.000236	CcSEcCtD
Tiagabine—Diarrhoea—Olmesartan—coronary artery disease	9.23e-05	0.000236	CcSEcCtD
Tiagabine—Headache—Eplerenone—coronary artery disease	9.23e-05	0.000236	CcSEcCtD
Tiagabine—Thrombocytopenia—Ramipril—coronary artery disease	9.2e-05	0.000235	CcSEcCtD
Tiagabine—Oedema—Timolol—coronary artery disease	9.19e-05	0.000235	CcSEcCtD
Tiagabine—Pruritus—Pravastatin—coronary artery disease	9.18e-05	0.000234	CcSEcCtD
Tiagabine—Loss of consciousness—Lisinopril—coronary artery disease	9.18e-05	0.000234	CcSEcCtD
Tiagabine—Nausea—Clopidogrel—coronary artery disease	9.18e-05	0.000234	CcSEcCtD
Tiagabine—Tachycardia—Ramipril—coronary artery disease	9.17e-05	0.000234	CcSEcCtD
Tiagabine—Infection—Timolol—coronary artery disease	9.13e-05	0.000233	CcSEcCtD
Tiagabine—Vomiting—Simvastatin—coronary artery disease	9.13e-05	0.000233	CcSEcCtD
Tiagabine—Hypersensitivity—Telmisartan—coronary artery disease	9.12e-05	0.000233	CcSEcCtD
Tiagabine—Cough—Lisinopril—coronary artery disease	9.11e-05	0.000233	CcSEcCtD
Tiagabine—Nausea—Lovastatin—coronary artery disease	9.11e-05	0.000233	CcSEcCtD
Tiagabine—Hyperhidrosis—Ramipril—coronary artery disease	9.09e-05	0.000232	CcSEcCtD
Tiagabine—Rash—Simvastatin—coronary artery disease	9.05e-05	0.000231	CcSEcCtD
Tiagabine—Dermatitis—Simvastatin—coronary artery disease	9.04e-05	0.000231	CcSEcCtD
Tiagabine—Asthenia—Trandolapril—coronary artery disease	9.04e-05	0.000231	CcSEcCtD
Tiagabine—Shock—Timolol—coronary artery disease	9.04e-05	0.000231	CcSEcCtD
Tiagabine—Feeling abnormal—Losartan—coronary artery disease	9.03e-05	0.000231	CcSEcCtD
Tiagabine—Urticaria—Furosemide—coronary artery disease	9.03e-05	0.000231	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	9.02e-05	0.000955	CbGpPWpGaD
Tiagabine—Diarrhoea—Niacin—coronary artery disease	9.02e-05	0.00023	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	9.01e-05	0.000954	CbGpPWpGaD
Tiagabine—Asthenia—Enalapril—coronary artery disease	9e-05	0.00023	CcSEcCtD
Tiagabine—Headache—Simvastatin—coronary artery disease	8.99e-05	0.00023	CcSEcCtD
Tiagabine—Body temperature increased—Furosemide—coronary artery disease	8.98e-05	0.000229	CcSEcCtD
Tiagabine—Abdominal pain—Furosemide—coronary artery disease	8.98e-05	0.000229	CcSEcCtD
Tiagabine—Gastrointestinal pain—Losartan—coronary artery disease	8.96e-05	0.000229	CcSEcCtD
Tiagabine—Dizziness—Valsartan—coronary artery disease	8.96e-05	0.000229	CcSEcCtD
Tiagabine—Anorexia—Ramipril—coronary artery disease	8.96e-05	0.000229	CcSEcCtD
Tiagabine—Nausea—Ezetimibe—coronary artery disease	8.94e-05	0.000228	CcSEcCtD
Tiagabine—Dizziness—Olmesartan—coronary artery disease	8.92e-05	0.000228	CcSEcCtD
Tiagabine—Pruritus—Trandolapril—coronary artery disease	8.91e-05	0.000228	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	8.9e-05	0.000942	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	8.9e-05	0.000942	CbGpPWpGaD
Tiagabine—Chest pain—Lisinopril—coronary artery disease	8.89e-05	0.000227	CcSEcCtD
Tiagabine—Myalgia—Lisinopril—coronary artery disease	8.89e-05	0.000227	CcSEcCtD
Tiagabine—Arthralgia—Lisinopril—coronary artery disease	8.89e-05	0.000227	CcSEcCtD
Tiagabine—Hyperhidrosis—Timolol—coronary artery disease	8.88e-05	0.000227	CcSEcCtD
Tiagabine—Asthenia—Telmisartan—coronary artery disease	8.88e-05	0.000227	CcSEcCtD
Tiagabine—Pruritus—Enalapril—coronary artery disease	8.88e-05	0.000227	CcSEcCtD
Tiagabine—Diarrhoea—Pravastatin—coronary artery disease	8.88e-05	0.000227	CcSEcCtD
Tiagabine—Anxiety—Lisinopril—coronary artery disease	8.86e-05	0.000226	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	8.81e-05	0.000933	CbGpPWpGaD
Tiagabine—Discomfort—Lisinopril—coronary artery disease	8.79e-05	0.000224	CcSEcCtD
Tiagabine—Hypotension—Ramipril—coronary artery disease	8.78e-05	0.000224	CcSEcCtD
Tiagabine—Anorexia—Timolol—coronary artery disease	8.76e-05	0.000224	CcSEcCtD
Tiagabine—Pruritus—Telmisartan—coronary artery disease	8.76e-05	0.000224	CcSEcCtD
Tiagabine—Nausea—Eplerenone—coronary artery disease	8.75e-05	0.000223	CcSEcCtD
Tiagabine—Dizziness—Niacin—coronary artery disease	8.71e-05	0.000223	CcSEcCtD
Tiagabine—Urticaria—Losartan—coronary artery disease	8.71e-05	0.000222	CcSEcCtD
Tiagabine—Dry mouth—Lisinopril—coronary artery disease	8.7e-05	0.000222	CcSEcCtD
Tiagabine—Body temperature increased—Losartan—coronary artery disease	8.67e-05	0.000221	CcSEcCtD
Tiagabine—Abdominal pain—Losartan—coronary artery disease	8.67e-05	0.000221	CcSEcCtD
Tiagabine—Asthenia—Captopril—coronary artery disease	8.64e-05	0.000221	CcSEcCtD
Tiagabine—Diarrhoea—Trandolapril—coronary artery disease	8.62e-05	0.00022	CcSEcCtD
Tiagabine—Vomiting—Valsartan—coronary artery disease	8.62e-05	0.00022	CcSEcCtD
Tiagabine—Confusional state—Lisinopril—coronary artery disease	8.6e-05	0.00022	CcSEcCtD
Tiagabine—Diarrhoea—Enalapril—coronary artery disease	8.59e-05	0.000219	CcSEcCtD
Tiagabine—Hypotension—Timolol—coronary artery disease	8.59e-05	0.000219	CcSEcCtD
Tiagabine—Dizziness—Pravastatin—coronary artery disease	8.58e-05	0.000219	CcSEcCtD
Tiagabine—Vomiting—Olmesartan—coronary artery disease	8.58e-05	0.000219	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.56e-05	0.000219	CcSEcCtD
Tiagabine—Rash—Valsartan—coronary artery disease	8.55e-05	0.000218	CcSEcCtD
Tiagabine—Dermatitis—Valsartan—coronary artery disease	8.54e-05	0.000218	CcSEcCtD
Tiagabine—Nausea—Simvastatin—coronary artery disease	8.52e-05	0.000218	CcSEcCtD
Tiagabine—Oedema—Lisinopril—coronary artery disease	8.52e-05	0.000218	CcSEcCtD
Tiagabine—Pruritus—Captopril—coronary artery disease	8.52e-05	0.000218	CcSEcCtD
Tiagabine—Rash—Olmesartan—coronary artery disease	8.5e-05	0.000217	CcSEcCtD
Tiagabine—Insomnia—Ramipril—coronary artery disease	8.5e-05	0.000217	CcSEcCtD
Tiagabine—Dermatitis—Olmesartan—coronary artery disease	8.5e-05	0.000217	CcSEcCtD
Tiagabine—Headache—Valsartan—coronary artery disease	8.49e-05	0.000217	CcSEcCtD
Tiagabine—Diarrhoea—Telmisartan—coronary artery disease	8.47e-05	0.000216	CcSEcCtD
Tiagabine—Infection—Lisinopril—coronary artery disease	8.47e-05	0.000216	CcSEcCtD
Tiagabine—Headache—Olmesartan—coronary artery disease	8.45e-05	0.000216	CcSEcCtD
Tiagabine—Paraesthesia—Ramipril—coronary artery disease	8.44e-05	0.000216	CcSEcCtD
Tiagabine—Shock—Lisinopril—coronary artery disease	8.39e-05	0.000214	CcSEcCtD
Tiagabine—Asthenia—Perindopril—coronary artery disease	8.38e-05	0.000214	CcSEcCtD
Tiagabine—Dyspnoea—Ramipril—coronary artery disease	8.38e-05	0.000214	CcSEcCtD
Tiagabine—Vomiting—Niacin—coronary artery disease	8.38e-05	0.000214	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Timolol—coronary artery disease	8.37e-05	0.000214	CcSEcCtD
Tiagabine—Hypersensitivity—Furosemide—coronary artery disease	8.37e-05	0.000214	CcSEcCtD
Tiagabine—Somnolence—Ramipril—coronary artery disease	8.36e-05	0.000213	CcSEcCtD
Tiagabine—Thrombocytopenia—Lisinopril—coronary artery disease	8.35e-05	0.000213	CcSEcCtD
Tiagabine—Dizziness—Trandolapril—coronary artery disease	8.33e-05	0.000213	CcSEcCtD
Tiagabine—Tachycardia—Lisinopril—coronary artery disease	8.32e-05	0.000213	CcSEcCtD
Tiagabine—Insomnia—Timolol—coronary artery disease	8.31e-05	0.000212	CcSEcCtD
Tiagabine—Rash—Niacin—coronary artery disease	8.31e-05	0.000212	CcSEcCtD
Tiagabine—Dermatitis—Niacin—coronary artery disease	8.3e-05	0.000212	CcSEcCtD
Tiagabine—Dizziness—Enalapril—coronary artery disease	8.3e-05	0.000212	CcSEcCtD
Tiagabine—Dyspepsia—Ramipril—coronary artery disease	8.27e-05	0.000211	CcSEcCtD
Tiagabine—Pruritus—Perindopril—coronary artery disease	8.27e-05	0.000211	CcSEcCtD
Tiagabine—Headache—Niacin—coronary artery disease	8.26e-05	0.000211	CcSEcCtD
Tiagabine—Paraesthesia—Timolol—coronary artery disease	8.25e-05	0.000211	CcSEcCtD
Tiagabine—Vomiting—Pravastatin—coronary artery disease	8.25e-05	0.000211	CcSEcCtD
Tiagabine—Hyperhidrosis—Lisinopril—coronary artery disease	8.24e-05	0.00021	CcSEcCtD
Tiagabine—Diarrhoea—Captopril—coronary artery disease	8.24e-05	0.00021	CcSEcCtD
Tiagabine—Dyspnoea—Timolol—coronary artery disease	8.19e-05	0.000209	CcSEcCtD
Tiagabine—Dizziness—Telmisartan—coronary artery disease	8.19e-05	0.000209	CcSEcCtD
Tiagabine—Rash—Pravastatin—coronary artery disease	8.18e-05	0.000209	CcSEcCtD
Tiagabine—Dermatitis—Pravastatin—coronary artery disease	8.17e-05	0.000209	CcSEcCtD
Tiagabine—Decreased appetite—Ramipril—coronary artery disease	8.17e-05	0.000209	CcSEcCtD
Tiagabine—Somnolence—Timolol—coronary artery disease	8.17e-05	0.000209	CcSEcCtD
Tiagabine—Asthenia—Furosemide—coronary artery disease	8.15e-05	0.000208	CcSEcCtD
Tiagabine—Headache—Pravastatin—coronary artery disease	8.13e-05	0.000208	CcSEcCtD
Tiagabine—Anorexia—Lisinopril—coronary artery disease	8.13e-05	0.000208	CcSEcCtD
Tiagabine—Fatigue—Ramipril—coronary artery disease	8.1e-05	0.000207	CcSEcCtD
Tiagabine—Dyspepsia—Timolol—coronary artery disease	8.09e-05	0.000207	CcSEcCtD
Tiagabine—Hypersensitivity—Losartan—coronary artery disease	8.08e-05	0.000206	CcSEcCtD
Tiagabine—Nausea—Valsartan—coronary artery disease	8.05e-05	0.000206	CcSEcCtD
Tiagabine—Pruritus—Furosemide—coronary artery disease	8.04e-05	0.000205	CcSEcCtD
Tiagabine—Constipation—Ramipril—coronary artery disease	8.04e-05	0.000205	CcSEcCtD
Tiagabine—Nausea—Olmesartan—coronary artery disease	8.01e-05	0.000205	CcSEcCtD
Tiagabine—Vomiting—Trandolapril—coronary artery disease	8.01e-05	0.000205	CcSEcCtD
Tiagabine—Diarrhoea—Perindopril—coronary artery disease	8e-05	0.000204	CcSEcCtD
Tiagabine—Decreased appetite—Timolol—coronary artery disease	7.99e-05	0.000204	CcSEcCtD
Tiagabine—Vomiting—Enalapril—coronary artery disease	7.98e-05	0.000204	CcSEcCtD
Tiagabine—Hypotension—Lisinopril—coronary artery disease	7.97e-05	0.000203	CcSEcCtD
Tiagabine—Dizziness—Captopril—coronary artery disease	7.96e-05	0.000203	CcSEcCtD
Tiagabine—Rash—Trandolapril—coronary artery disease	7.94e-05	0.000203	CcSEcCtD
Tiagabine—Dermatitis—Trandolapril—coronary artery disease	7.94e-05	0.000203	CcSEcCtD
Tiagabine—Fatigue—Timolol—coronary artery disease	7.92e-05	0.000202	CcSEcCtD
Tiagabine—Rash—Enalapril—coronary artery disease	7.91e-05	0.000202	CcSEcCtD
Tiagabine—Dermatitis—Enalapril—coronary artery disease	7.91e-05	0.000202	CcSEcCtD
Tiagabine—Headache—Trandolapril—coronary artery disease	7.89e-05	0.000202	CcSEcCtD
Tiagabine—Vomiting—Telmisartan—coronary artery disease	7.87e-05	0.000201	CcSEcCtD
Tiagabine—Asthenia—Losartan—coronary artery disease	7.86e-05	0.000201	CcSEcCtD
Tiagabine—Headache—Enalapril—coronary artery disease	7.86e-05	0.000201	CcSEcCtD
Tiagabine—Pain—Timolol—coronary artery disease	7.86e-05	0.000201	CcSEcCtD
Tiagabine—Nausea—Niacin—coronary artery disease	7.83e-05	0.0002	CcSEcCtD
Tiagabine—Rash—Telmisartan—coronary artery disease	7.8e-05	0.000199	CcSEcCtD
Tiagabine—Dermatitis—Telmisartan—coronary artery disease	7.8e-05	0.000199	CcSEcCtD
Tiagabine—Diarrhoea—Furosemide—coronary artery disease	7.77e-05	0.000199	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.77e-05	0.000198	CcSEcCtD
Tiagabine—Pruritus—Losartan—coronary artery disease	7.76e-05	0.000198	CcSEcCtD
Tiagabine—Headache—Telmisartan—coronary artery disease	7.75e-05	0.000198	CcSEcCtD
Tiagabine—Feeling abnormal—Ramipril—coronary artery disease	7.75e-05	0.000198	CcSEcCtD
Tiagabine—Dizziness—Perindopril—coronary artery disease	7.73e-05	0.000197	CcSEcCtD
Tiagabine—Insomnia—Lisinopril—coronary artery disease	7.71e-05	0.000197	CcSEcCtD
Tiagabine—Nausea—Pravastatin—coronary artery disease	7.71e-05	0.000197	CcSEcCtD
Tiagabine—Gastrointestinal pain—Ramipril—coronary artery disease	7.69e-05	0.000196	CcSEcCtD
Tiagabine—Paraesthesia—Lisinopril—coronary artery disease	7.65e-05	0.000196	CcSEcCtD
Tiagabine—Vomiting—Captopril—coronary artery disease	7.65e-05	0.000195	CcSEcCtD
Tiagabine—Dyspnoea—Lisinopril—coronary artery disease	7.6e-05	0.000194	CcSEcCtD
Tiagabine—Rash—Captopril—coronary artery disease	7.59e-05	0.000194	CcSEcCtD
Tiagabine—Dermatitis—Captopril—coronary artery disease	7.58e-05	0.000194	CcSEcCtD
Tiagabine—Somnolence—Lisinopril—coronary artery disease	7.58e-05	0.000194	CcSEcCtD
Tiagabine—Feeling abnormal—Timolol—coronary artery disease	7.57e-05	0.000193	CcSEcCtD
Tiagabine—Headache—Captopril—coronary artery disease	7.54e-05	0.000193	CcSEcCtD
Tiagabine—Gastrointestinal pain—Timolol—coronary artery disease	7.51e-05	0.000192	CcSEcCtD
Tiagabine—Dizziness—Furosemide—coronary artery disease	7.51e-05	0.000192	CcSEcCtD
Tiagabine—Dyspepsia—Lisinopril—coronary artery disease	7.5e-05	0.000192	CcSEcCtD
Tiagabine—Diarrhoea—Losartan—coronary artery disease	7.5e-05	0.000192	CcSEcCtD
Tiagabine—Nausea—Trandolapril—coronary artery disease	7.48e-05	0.000191	CcSEcCtD
Tiagabine—Urticaria—Ramipril—coronary artery disease	7.47e-05	0.000191	CcSEcCtD
Tiagabine—Nausea—Enalapril—coronary artery disease	7.45e-05	0.00019	CcSEcCtD
Tiagabine—Vomiting—Perindopril—coronary artery disease	7.43e-05	0.00019	CcSEcCtD
Tiagabine—Abdominal pain—Ramipril—coronary artery disease	7.43e-05	0.00019	CcSEcCtD
Tiagabine—Body temperature increased—Ramipril—coronary artery disease	7.43e-05	0.00019	CcSEcCtD
Tiagabine—Decreased appetite—Lisinopril—coronary artery disease	7.41e-05	0.000189	CcSEcCtD
Tiagabine—Rash—Perindopril—coronary artery disease	7.37e-05	0.000188	CcSEcCtD
Tiagabine—Dermatitis—Perindopril—coronary artery disease	7.36e-05	0.000188	CcSEcCtD
Tiagabine—Nausea—Telmisartan—coronary artery disease	7.35e-05	0.000188	CcSEcCtD
Tiagabine—Fatigue—Lisinopril—coronary artery disease	7.35e-05	0.000188	CcSEcCtD
Tiagabine—Headache—Perindopril—coronary artery disease	7.32e-05	0.000187	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	7.31e-05	0.000774	CbGpPWpGaD
Tiagabine—Urticaria—Timolol—coronary artery disease	7.3e-05	0.000186	CcSEcCtD
Tiagabine—Pain—Lisinopril—coronary artery disease	7.29e-05	0.000186	CcSEcCtD
Tiagabine—Constipation—Lisinopril—coronary artery disease	7.29e-05	0.000186	CcSEcCtD
Tiagabine—Abdominal pain—Timolol—coronary artery disease	7.26e-05	0.000186	CcSEcCtD
Tiagabine—Body temperature increased—Timolol—coronary artery disease	7.26e-05	0.000186	CcSEcCtD
Tiagabine—Dizziness—Losartan—coronary artery disease	7.25e-05	0.000185	CcSEcCtD
Tiagabine—Vomiting—Furosemide—coronary artery disease	7.22e-05	0.000185	CcSEcCtD
Tiagabine—Rash—Furosemide—coronary artery disease	7.16e-05	0.000183	CcSEcCtD
Tiagabine—Dermatitis—Furosemide—coronary artery disease	7.16e-05	0.000183	CcSEcCtD
Tiagabine—Nausea—Captopril—coronary artery disease	7.15e-05	0.000183	CcSEcCtD
Tiagabine—Headache—Furosemide—coronary artery disease	7.12e-05	0.000182	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	7.1e-05	0.000752	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	7.06e-05	0.000748	CbGpPWpGaD
Tiagabine—Feeling abnormal—Lisinopril—coronary artery disease	7.02e-05	0.000179	CcSEcCtD
Tiagabine—Gastrointestinal pain—Lisinopril—coronary artery disease	6.97e-05	0.000178	CcSEcCtD
Tiagabine—Vomiting—Losartan—coronary artery disease	6.97e-05	0.000178	CcSEcCtD
Tiagabine—Nausea—Perindopril—coronary artery disease	6.94e-05	0.000177	CcSEcCtD
Tiagabine—Hypersensitivity—Ramipril—coronary artery disease	6.92e-05	0.000177	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	6.92e-05	0.000733	CbGpPWpGaD
Tiagabine—Rash—Losartan—coronary artery disease	6.91e-05	0.000177	CcSEcCtD
Tiagabine—Dermatitis—Losartan—coronary artery disease	6.91e-05	0.000176	CcSEcCtD
Tiagabine—Headache—Losartan—coronary artery disease	6.87e-05	0.000175	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	6.83e-05	0.000723	CbGpPWpGaD
Tiagabine—Urticaria—Lisinopril—coronary artery disease	6.77e-05	0.000173	CcSEcCtD
Tiagabine—Hypersensitivity—Timolol—coronary artery disease	6.77e-05	0.000173	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	6.76e-05	0.000715	CbGpPWpGaD
Tiagabine—Nausea—Furosemide—coronary artery disease	6.75e-05	0.000172	CcSEcCtD
Tiagabine—Asthenia—Ramipril—coronary artery disease	6.74e-05	0.000172	CcSEcCtD
Tiagabine—Abdominal pain—Lisinopril—coronary artery disease	6.74e-05	0.000172	CcSEcCtD
Tiagabine—Body temperature increased—Lisinopril—coronary artery disease	6.74e-05	0.000172	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GCLC—coronary artery disease	6.68e-05	0.000707	CbGpPWpGaD
Tiagabine—Pruritus—Ramipril—coronary artery disease	6.65e-05	0.00017	CcSEcCtD
Tiagabine—Asthenia—Timolol—coronary artery disease	6.59e-05	0.000168	CcSEcCtD
Tiagabine—Nausea—Losartan—coronary artery disease	6.51e-05	0.000166	CcSEcCtD
Tiagabine—Pruritus—Timolol—coronary artery disease	6.5e-05	0.000166	CcSEcCtD
Tiagabine—Diarrhoea—Ramipril—coronary artery disease	6.43e-05	0.000164	CcSEcCtD
Tiagabine—Diarrhoea—Timolol—coronary artery disease	6.29e-05	0.000161	CcSEcCtD
Tiagabine—Hypersensitivity—Lisinopril—coronary artery disease	6.28e-05	0.00016	CcSEcCtD
Tiagabine—Dizziness—Ramipril—coronary artery disease	6.22e-05	0.000159	CcSEcCtD
Tiagabine—Asthenia—Lisinopril—coronary artery disease	6.12e-05	0.000156	CcSEcCtD
Tiagabine—Dizziness—Timolol—coronary artery disease	6.08e-05	0.000155	CcSEcCtD
Tiagabine—Pruritus—Lisinopril—coronary artery disease	6.03e-05	0.000154	CcSEcCtD
Tiagabine—Vomiting—Ramipril—coronary artery disease	5.98e-05	0.000153	CcSEcCtD
Tiagabine—Rash—Ramipril—coronary artery disease	5.93e-05	0.000151	CcSEcCtD
Tiagabine—Dermatitis—Ramipril—coronary artery disease	5.92e-05	0.000151	CcSEcCtD
Tiagabine—Headache—Ramipril—coronary artery disease	5.89e-05	0.00015	CcSEcCtD
Tiagabine—Vomiting—Timolol—coronary artery disease	5.84e-05	0.000149	CcSEcCtD
Tiagabine—Diarrhoea—Lisinopril—coronary artery disease	5.83e-05	0.000149	CcSEcCtD
Tiagabine—Rash—Timolol—coronary artery disease	5.79e-05	0.000148	CcSEcCtD
Tiagabine—Dermatitis—Timolol—coronary artery disease	5.79e-05	0.000148	CcSEcCtD
Tiagabine—Headache—Timolol—coronary artery disease	5.76e-05	0.000147	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	5.73e-05	0.000606	CbGpPWpGaD
Tiagabine—Dizziness—Lisinopril—coronary artery disease	5.64e-05	0.000144	CcSEcCtD
Tiagabine—Nausea—Ramipril—coronary artery disease	5.58e-05	0.000143	CcSEcCtD
Tiagabine—Nausea—Timolol—coronary artery disease	5.46e-05	0.000139	CcSEcCtD
Tiagabine—Vomiting—Lisinopril—coronary artery disease	5.42e-05	0.000138	CcSEcCtD
Tiagabine—Rash—Lisinopril—coronary artery disease	5.37e-05	0.000137	CcSEcCtD
Tiagabine—Dermatitis—Lisinopril—coronary artery disease	5.37e-05	0.000137	CcSEcCtD
Tiagabine—Headache—Lisinopril—coronary artery disease	5.34e-05	0.000136	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GGT1—coronary artery disease	5.21e-05	0.000552	CbGpPWpGaD
Tiagabine—Nausea—Lisinopril—coronary artery disease	5.06e-05	0.000129	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—CA5B—coronary artery disease	4.73e-05	0.000501	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	4.68e-05	0.000496	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	4.62e-05	0.000489	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	4.3e-05	0.000456	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	4.24e-05	0.000449	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CKMT1B—coronary artery disease	4.03e-05	0.000426	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	3.28e-05	0.000347	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CKM—coronary artery disease	3.28e-05	0.000347	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPAP2B—coronary artery disease	3.28e-05	0.000347	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PDK4—coronary artery disease	3.05e-05	0.000323	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PYGM—coronary artery disease	3.05e-05	0.000323	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SULT4A1—coronary artery disease	3.05e-05	0.000323	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CKMT2—coronary artery disease	3.05e-05	0.000323	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	3.05e-05	0.000323	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—POMC—coronary artery disease	3.04e-05	0.000322	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PFKM—coronary artery disease	2.72e-05	0.000288	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GYG1—coronary artery disease	2.72e-05	0.000288	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GK—coronary artery disease	2.72e-05	0.000288	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LDHA—coronary artery disease	2.72e-05	0.000288	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.72e-05	0.000288	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GATM—coronary artery disease	2.72e-05	0.000288	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCH1—coronary artery disease	2.59e-05	0.000275	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AK1—coronary artery disease	2.59e-05	0.000275	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MDH2—coronary artery disease	2.49e-05	0.000263	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UGCG—coronary artery disease	2.49e-05	0.000263	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPAT—coronary artery disease	2.49e-05	0.000263	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLCD1—coronary artery disease	2.49e-05	0.000263	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PGM1—coronary artery disease	2.39e-05	0.000253	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PYGB—coronary artery disease	2.31e-05	0.000245	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CKB—coronary artery disease	2.31e-05	0.000245	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DLAT—coronary artery disease	2.17e-05	0.00023	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	2.17e-05	0.00023	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—COX5B—coronary artery disease	2.17e-05	0.00023	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLIN1—coronary artery disease	2.17e-05	0.00023	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTM2—coronary artery disease	2.17e-05	0.00023	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	2.06e-05	0.000218	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.97e-05	0.000208	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HK2—coronary artery disease	1.97e-05	0.000208	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.88e-05	0.0002	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.85e-05	0.000196	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LCAT—coronary artery disease	1.85e-05	0.000196	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOA4—coronary artery disease	1.81e-05	0.000192	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCLM—coronary artery disease	1.75e-05	0.000186	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.75e-05	0.000186	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.7e-05	0.00018	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.7e-05	0.00018	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.67e-05	0.000177	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.65e-05	0.000174	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HADH—coronary artery disease	1.65e-05	0.000174	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.56e-05	0.000165	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOA2—coronary artery disease	1.56e-05	0.000165	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX2—coronary artery disease	1.56e-05	0.000165	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX4—coronary artery disease	1.54e-05	0.000163	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.54e-05	0.000163	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.54e-05	0.000163	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HK1—coronary artery disease	1.54e-05	0.000163	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HADHA—coronary artery disease	1.52e-05	0.000161	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.51e-05	0.00016	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LPA—coronary artery disease	1.49e-05	0.000158	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.44e-05	0.000153	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOA5—coronary artery disease	1.43e-05	0.000151	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—P4HB—coronary artery disease	1.4e-05	0.000148	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.38e-05	0.000146	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—VCAN—coronary artery disease	1.3e-05	0.000137	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.29e-05	0.000136	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DCN—coronary artery disease	1.25e-05	0.000132	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.21e-05	0.000129	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.18e-05	0.000125	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LIPC—coronary artery disease	1.18e-05	0.000125	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HBA1—coronary artery disease	1.18e-05	0.000125	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.18e-05	0.000125	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOC3—coronary artery disease	1.18e-05	0.000125	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LDLR—coronary artery disease	1.17e-05	0.000124	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.16e-05	0.000122	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.16e-05	0.000122	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CETP—coronary artery disease	1.14e-05	0.000121	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCLC—coronary artery disease	1.14e-05	0.000121	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SDC1—coronary artery disease	1.13e-05	0.00012	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.07e-05	0.000113	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.07e-05	0.000113	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CTGF—coronary artery disease	1.04e-05	0.00011	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GOT2—coronary artery disease	1.03e-05	0.000109	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.03e-05	0.000109	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLCB1—coronary artery disease	9.5e-06	0.000101	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCA1—coronary artery disease	9.21e-06	9.75e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GOT1—coronary artery disease	8.92e-06	9.44e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GGT1—coronary artery disease	8.92e-06	9.44e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTP1—coronary artery disease	8.01e-06	8.48e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	7.93e-06	8.4e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMOX1—coronary artery disease	7.9e-06	8.36e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAT—coronary artery disease	7.79e-06	8.25e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOB—coronary artery disease	7.56e-06	8.01e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTM1—coronary artery disease	7.36e-06	7.79e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LPL—coronary artery disease	7.22e-06	7.65e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX1—coronary artery disease	7.05e-06	7.46e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CD36—coronary artery disease	6.86e-06	7.27e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	6.78e-06	7.18e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTHFR—coronary artery disease	6.5e-06	6.89e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AGT—coronary artery disease	6.18e-06	6.54e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOE—coronary artery disease	6.05e-06	6.41e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOA1—coronary artery disease	5.99e-06	6.34e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARG—coronary artery disease	5.27e-06	5.58e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—POMC—coronary artery disease	5.2e-06	5.51e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—coronary artery disease	4.74e-06	5.02e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NOS3—coronary artery disease	4.54e-06	4.8e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.15e-06	4.39e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.55e-06	2.7e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.09e-06	2.21e-05	CbGpPWpGaD
